Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  34 results for ""FENOFIBRATE""

Your Filters

Language : japanese
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[The nuclear receptor PPARα (peroxisome proliferator-activated receptor α) as a novel therapeutic target for schizophrenia].

  • Authors : Maekawa M; Department of Organ Anatomy, Tohoku University Graduate School of Medicine.

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; PPAR alpha*/PPAR alpha*/PPAR alpha*/genetics

  • Source: Nihon yakurigaku zasshi. Folia pharmacologica Japonica [Nihon Yakurigaku Zasshi] 2023 May 01; Vol. 158 (3), pp. 238-241. Date of Electronic Publication: 2023 Mar 29.Publisher: Nippon Yakuri Gakkai Country of Publication: Japan NLM ID: 0420550 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Fenofibrate].

  • Authors : Yamashita T; Department of Internal Medicine, Mitsukoshi Health & Welfare Foundation.; Nakamura H

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/pharmacology

  • Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2001 Mar; Vol. 59 Suppl 3, pp. 618-24.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study].

  • Authors : Ai M; Department of Life Sciences and Bioethics, Graduate School of Medicine, Tokyo Medical and Dental University.; Yoshida M

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Retinopathy/Diabetic Retinopathy/Diabetic Retinopathy/*prevention & control ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use

  • Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2010 Nov; Vol. 68 Suppl 9, pp. 285-90.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Studies on the risk factors for fenofibrate-induced elevation of liver function tests].

  • Authors : Hayakawa T; Department of Pharmacy, Sapporo Kosei Hospital, Higashi-8, Kita-3, Chuo-ku, Sapporo, Hokkaido 060-0033, Japan. ; Hayashi A

Subjects: Liver Function Tests*; Fenofibrate/Fenofibrate/Fenofibrate/*adverse effects ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*adverse effects

  • Source: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2002 Feb; Vol. 122 (2), pp. 169-75.Publisher: Nihon Yakugakkai Country of Publication: Japan NLM ID: 0413613 Publication Model: Print Cited Medium: Print ISSN: 0031-6903 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I: Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits].

  • Authors : Saitoh K; Research Center, Grelan Pharmaceutical Co., Ltd., Tokyo, Japan.; Mori T

Subjects: Arteriosclerosis/Arteriosclerosis/Arteriosclerosis/*drug therapy ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Nihon yakurigaku zasshi. Folia pharmacologica Japonica [Nihon Yakurigaku Zasshi] 1995 Jul; Vol. 106 (1), pp. 41-50.Publisher: Nippon Yakuri Gakkai Country of Publication: Japan NLM ID: 0420550 Publication Model: Print Cited Medium: Print ISSN: 0015-5691

Record details

Read More Add to Saved list
×
Academic Journal

[Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. II: Anti-atheromatous effects are independent of its hypolipidemic effect in hereditary hyperlipidemic rabbits].

  • Authors : Saitoh K; Research Center, Grelan Pharmaceutical Co., Ltd., Tokyo, Japan.; Mori T

Subjects: Arteriosclerosis/Arteriosclerosis/Arteriosclerosis/*drug therapy ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*blood

  • Source: Nihon yakurigaku zasshi. Folia pharmacologica Japonica [Nihon Yakurigaku Zasshi] 1995 Jul; Vol. 106 (1), pp. 51-60.Publisher: Nippon Yakuri Gakkai Country of Publication: Japan NLM ID: 0420550 Publication Model: Print Cited Medium: Print ISSN: 0015-5691

Record details

Read More Add to Saved list
×
Academic Journal

[High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine].

  • Authors : Abe S; Grelan Pharmaceutical Co., Ltd., Tokyo, Japan.; Ono K

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*analysis ; Fenofibrate/Fenofibrate/Fenofibrate/*analogs & derivatives ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*analysis

  • Source: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 1998 Oct; Vol. 118 (10), pp. 447-55.Publisher: Nihon Yakugakkai Country of Publication: Japan NLM ID: 0413613 Publication Model: Print Cited Medium: Print ISSN: 0031-6903 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Pleiotrophic effect of anti-hyperlipemic agents].

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*pharmacology ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology

  • Source: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine [Nihon Naika Gakkai Zasshi] 2001 Oct 10; Vol. 90 (10), pp. 2017-22.Publisher: Nihon Naika Gakkai Country of Publication: Japan NLM ID: 19130210R Publication Model: Print Cited Medium: Print ISSN: 0021-5384

Record details

Read More Add to Saved list
×
Academic Journal

[Other antihyperuricemic agents].

  • Authors : Ogino K; Center for Clinical Residency Program, Tottori University Hospital.; Igawa O

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Gout Suppressants/Gout Suppressants/Gout Suppressants/*therapeutic use

  • Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2008 Apr; Vol. 66 (4), pp. 754-7.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Fibrates].

  • Authors : Yamada N; Institute of Clinical Medicine, University of Tsukuba.

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use; Bezafibrate/Bezafibrate/Bezafibrate/therapeutic use

  • Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2002 May; Vol. 60 (5), pp. 962-7.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details

Read More Add to Saved list
×
  • 1-10 of  34 results for ""FENOFIBRATE""